1.
Aberrant IgA responses to the gut microbiota during infancy precede asthma and allergy development
by Dzidic, Majda, MSc
Journal of allergy and clinical immunology, 2016, Vol.139 (3), p.1017-1025.e14
2.
Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study)
by Shima, Yuko
Pediatric nephrology (Berlin, West), 2018, Vol.34 (5), p.837-846
3.
Clinicopathologic Features of IgA-Dominant Infection-Associated Glomerulonephritis: A Pooled Analysis of 78 Cases
by Bu, Ru
American journal of nephrology, 2015, Vol.41 (2), p.98-106
4.
Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy
by Hwang, Jin Ho
American journal of nephrology, 2016, Vol.44 (6), p.481-492
5.
Steroid therapy in children with IgA nephropathy
by Cambier, Alexandra
Pediatric nephrology (Berlin, West), 2019, Vol.35 (3), p.359-366
6.
Association Between IgA Deficiency & Other Autoimmune Conditions: A Population-Based Matched Cohort Study
by Ludvigsson, Jonas F
Journal of clinical immunology, 2014, Vol.34 (4), p.444-451
7.
Primary glomerulonephritides
by Floege, Jürgen, Prof
The Lancet (British edition), 2016, Vol.387 (10032), p.2036-2048
8.
Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy
by Mizerska-Wasiak, Małgorzata
Pediatric nephrology (Berlin, West), 2014, Vol.30 (7), p.1113-1120
9.
The gut–kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition
by Coppo, Rosanna
Pediatric nephrology (Berlin, West), 2017, Vol.33 (1), p.53-61
10.
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
by Fellström, Bengt C, Prof
The Lancet (British edition), 2017, Vol.389 (10084), p.2117-2127
11.
Pathogenesis of Immunoglobulin A Nephropathy: Recent Insight from Genetic Studies
by Kiryluk, Krzysztof
Annual review of medicine, 2013, Vol.64 (1), p.339-356
12.
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort
by Coppo, Rosanna
Pediatric nephrology (Berlin, West), 2016, Vol.32 (1), p.139-150
13.
14.
IgA nephropathy in a child: Crohn's disease-associated or adalimumab induced?
by Graziano, Francesco
Current medical research and opinion, 2022, Vol.38 (1), p.139-143
15.
Eculizumab treatment for rescue of renal function in IgA nephropathy
by Rosenblad, Therese
Pediatric nephrology (Berlin, West), 2014, Vol.29 (11), p.2225-2228
16.
Autoimmunity in IgA Deficiency: Revisiting the Role of IgA as a Silent Housekeeper
by Jacob, Cristina M. A
Journal of clinical immunology, 2008, Vol.28 (Suppl 1), p.56-61
17.
Selective IgA Deficiency
by Yel, Leman
Journal of clinical immunology, 2010, Vol.30 (1), p.10-16
18.
Evolution of IgA nephropathy into anaphylactoid purpura in six cases—further evidence that IgA nephropathy and Henoch–Schonlein purpura nephritis share common pathogenesis
by Kamei, Koichi
Pediatric nephrology (Berlin, West), 2015, Vol.31 (5), p.779-785
19.
Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy
by Knoop, Thomas
American journal of nephrology, 2015, Vol.41 (3), p.210-219
20.
IgA Deficiency: Correlation Between Clinical and Immunological Phenotypes
by Aghamohammadi, Asghar
Journal of clinical immunology, 2008, Vol.29 (1), p.130-136
